Development and validation of stability indicating HPLC assay method for
simultaneous determination of amlodipine besylate, olmesartan medoxomil
and hydrochlorothiazide in tablet formulation
The purpose of the research described herein was to develop simple, precise and accurate isocratic stability
indicating reversed phase HPLC assay method for determination of simultaneous determination of Amlodipine
besylate, Olmesartan medoxomil and Hydrochlorothiazide solid dosage forms. Isocratic RP-HPLC method was
developed on Phenomenex Gemini C18 250ÃÆââ¬Å¡Ãâô 4.6mm, 5ÃÆÃ
½Ãâüm column using mobile phase as 0.02M ammonium acetate
buffer pH 4.5 - Acetonitrile (60:40, v/v) at a flow rate of 1.0 ml/min and the detection was carried out at 241 nm
using photo-diode array detector. The drug was subjected to oxidation, hydrolysis, photolysis and heat to apply
stress condition. The validation element investigated showed that the method has acceptable specificity, accuracy,
linearity, solution stability, precision and robustness.
Author(s): Gaurang P. Pandya and Hitendra S. Joshi
Abstract |
PDF
Share This Article